Donald M. Thea
sph.bu.edu
0000-0002-6933-1030
Boston University
188 papers found
Refreshing results…
The effect of maternal viral load on the risk of perinatal transmission of HIV-1:
Early Detection of Perinatal Human Immunodeficiency Virus (HIV) Type 1 Infection Using HIV RNA Amplification and Detection
Timing of maternal-infant HIV transmission
Vitamin A Deficiency and Maternal-Infant Transmission of HIV in Two Metropolitan Areas in the United States:
Lack of increased risk for perinatal human immunodeficiency virus transmission to subsequent children born to infected women:
Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City:
Heterosexual behavior during pregnancy and perinatal transmission of HIV-1:
Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period. The New York City Perinatal HIV Transmission Collaborative Study Group.
Plasma Cytokines, Cytokine Antagonists, and Disease Progression in African Women Infected with HIV-1
The effect of maternal viral load on the risk of perinatal transmission of HIV-I
Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Different body composition changes in men and women with AIDS
Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period [10]
Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants
Comparison of methods of estimating the mother-to-child transmission rate of human immunodeficiency virus type 1 (HIV-1). New York City Perinatal HIV Transmission Collaborative Study Group.
Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group.
Efficacy of Antenatal Zidovudine in Reducing Perinatal Transmission of Human Immunodeficiency Virus Type 1
Ethical Issues in the Use of Zidovudine to Reduce Vertical Transmission of HIV
Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth
Missing publications? Search for publications with a matching author name.